Generative Tissues, or gTissues, represent a specialized category of living tissue in biology. They are surgically created, cultivated within a patient, and possess a distinctive cellular and biochemical composition that sets them apart from other bodily tissues. The inception of gTissues emerged from advancements in Tissue Engineering and Regenerative Medicine, initially observed during the reconstruction of canine dura mater, resulting in the formation of a dense connective tissue between the brain and skull.[1] Subsequently, this technology has been successfully employed in humans for diverse clinical applications, particularly in soft tissue healing and repair. The creation of gTissue involves the surgical implantation of specific non-inflammatory Extracellular Matrix (ECM) biomaterials, which are embraced by the host. This process includes the integration of host cells and blood vessels, ultimately transforming the implanted material into a living tissue. Variants of gTissue developed so far predominantly mirror soft connective tissues like dermis, tendon, ligament, and fascia. The generation of gTissue commences with the implantation of cell-free ECM biomaterial, which progressively integrates with the host. Immediately post-implantation, the porous material absorbs blood, initiating a seeding process with circulating stem cells and growth factors crucial for gTissue development. As the generation proceeds, signals from growth factors, cytokines, and the fibrin provisional matrix prompt host cells to repopulate the matrix. Simultaneously, a vascular network is established within the ECM biomaterial to support the metabolic activity of these cells.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States